Navigation Links
Gene found to play a suppressor role in skin cancer development
Date:2/6/2008

Researchers at the Burnham Institute for Medical Research (Burnham Institute) have provided genetic evidence that Activating Transcription Factor 2 (ATF2) plays a suppressor role in skin cancer development. ATF2 is a protein that regulates gene transcription, which is the first step in the translation of genetic code, in response to extracellular stresses such as ultraviolet light and ionizing radiation. This function of ATF2 in stress and DNA damage response suggests that it may also play a role in the formation of tumors.

Previous studies led by Zeev Ronai, Ph.D. have suggested an important role of ATF2 in melanoma development and progression. In this new study, published in this weeks issue of Proceedings of the National Academy of Sciences of the United States of America, the Ronai laboratory, in collaboration with Nic Jones, Ph.D. from the University of Manchester UK, used a mouse model that expresses a transcriptionally inactive form of ATF2 in skin cells (keratinocytes). When the mice were subjected to chemically mediated skin carcinogenesis, tumors appeared faster and more frequently. These findings reveal that loss of ATF2 transcriptional activity in skin exposed to carcinogens enhances skin tumor formation, suggesting a tumor suppressor role for ATF2 in keratinocytes.

Important support for the finding comes from the analysis of tumor samples from human patients with non malignant skin cancer, states Dr. Ronai. Unlike the strong nuclear expression of ATF2 in normal skin, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) samples exhibit a significantly reduced nuclear staining for ATF2.

The analysis of human skin cell carcinomas are also consistent with the reduced expression of ATF2 found in the papillomas that developed in the wild-type animals in this study, supporting the notion that ATF2 needs to be inactivated to support skin tumor development.

The group also identified ATF2 as an upstream regulator of genes including Presenilin1 (PS1), Notch1, and -catenin, all of which have previously been reported to be involved in skin tumor development; thus providing an example of a mechanism by which ATF2 functions as a tumor suppressor.


'/>"/>

Contact: Andrea Moser
communications@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert  

Related medicine news :

1. Very young found to process fear memories in unique way
2. Texas Senator Tommy Williams Honored as Champion for Children by the AMERIGROUP Foundation
3. Foundations to Strengthen State Health Care Reform Advocacy
4. Agatston Research Foundation Sponsors New Childhood Obesity Initiative
5. LOreal USA Announces Three-Year Support of Womens Dermatologic Society Foundation Community Outreach
6. Avon Foundation Brings Together Breast Cancer Experts in Houston to Report Significant New Data
7. 2 genes found to play crucial role in cell survival
8. Model found to determine cause, possible treatment of nerve tumors
9. R Baby Foundation Raises $2.5 Million in First Year
10. Simons Foundation grant boosts brain tumor research
11. The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene found to play a suppressor role in skin cancer development
(Date:6/28/2017)... ... June 28, 2017 , ... ... communities throughout the greater Cincinnati metropolitan area, is teaming up with the local ... families with children receiving treatment in nearby hospitals. , Ronald McDonald House of ...
(Date:6/27/2017)... ... 2017 , ... Harbour , a DAO (decentralized autonomous organization) that harnesses ... released their technical specifications . , 2017 has seen an explosion of token ... determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
(Date:6/27/2017)... New York, NY (PRWEB) , ... June 27, ... ... communications and marketing experts to contribute to an upcoming case studies guidebook. This ... or her organization. , This book will include articles, case studies and how-to’s ...
(Date:6/27/2017)... ... ... Hammer Strength, the world’s leading performance strength training brand, and the National ... the NBSCA Strength & Conditioning Coach of the Year. , In its 11th ... select the coach who embodies the highest level of excellence and outstanding service to ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... BLUE BELL, Pa. , June 1, 2017 /PRNewswire/ ... Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD ... direct investment in Nutriceutical Holdings by KD Pharma Group. ... Nutriceutical Holdings with the option to acquire the entire ... ideal partner in KD. They are committed to growing ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... , May 25, 2017  In response to the ... , Direct Relief is working with Pfizer to make ... at no cost to community health centers, free and ... nationwide. "Pfizer has a long-standing commitment ... and ensuring patient safety through educational activities," said ...
Breaking Medicine Technology: